New Weight Loss Pill Orforglipron Rivals Ozempic in Effectiveness

 

Orforglipron mimics a hormone that regulates blood sugar levels and suppresses appetite (PlushCare).

A groundbreaking study has revealed that a new experimental oral drug, Orforglipron, shows weight loss and blood sugar regulation results similar to the weekly injectable Ozempic (semaglutide).


Researchers presented the findings at the American Diabetes Association Annual Meeting, held June 20–23 in Chicago, Illinois. The results have generated widespread interest among doctors, investors, and those seeking effective, non-injectable weight loss medications.


What is Orforglipron?


Orforglipron is an oral GLP-1 receptor agonist, mimicking a hormone that helps control blood sugar levels and suppress appetite—just like Ozempic, Wegovy, and other popular GLP-1-based weight loss medications.


In a clinical trial involving over 500 participants with type 2 diabetes, those on the highest dose lost an average of 16 pounds (approx. 7.25 kg) over 9 months. Two-thirds also experienced significant improvements in blood glucose levels.



Why Orforglipron is Generating Buzz


With increasing demand for injectable-free weight loss solutions, Orforglipron is a promising option. Analysts estimate that 1 in 8 U.S. adults has tried GLP-1 medications like Wegovy or Zepbound, and many more may prefer a daily pill over weekly injections.


Eli Lilly, the pharmaceutical company behind Orforglipron, plans to release further study data later this year focusing on its use in obese individuals. The company is initially seeking regulatory approval to market Orforglipron for obesity, followed by approval for type 2 diabetes treatment.


Though pricing hasn't been announced, oral drugs are typically cheaper to produce than injectables.



GLP-1 Agonists: A Powerful Class of Weight Loss Medications


GLP-1 receptor agonists have revolutionized diabetes and weight management. These medications help:


  • Lower blood sugar
  • Promote significant weight loss
  • Reduce appetite


Popular GLP-1 agonists include:


  • Ozempic (semaglutide injection)
  • Wegovy (semaglutide for weight loss)
  • Rybelsus (oral semaglutide)
  • Trulicity (dulaglutide)
  • Saxenda (liraglutide for weight loss)
  • Bydureon, Byetta, Victoza, and others


While most GLP-1 medications require injections, Orforglipron offers a needle-free alternative with similar efficacy.



More Experimental Weight Loss Drugs on the Horizon


Orforglipron is just one of over a dozen experimental drugs shared at the ADA conference. Some are still in early clinical stages, while others may enter the market by next year.


Promising new weight loss drugs aim to:


  • Deliver 15%–20%+ body weight loss
  • Be more convenient than weekly injections
  • Preserve lean muscle mass during fat loss



One such drug, MariTide (by Amgen), is a monthly injectable under development. Another compound combines Ozempic's active ingredient with agents that regulate muscle and fat metabolism, potentially avoiding muscle loss—a common side effect of rapid weight loss.


Several other compounds under development mimic the hormone amylin, which in animal studies has shown the potential to protect lean muscle tissue during fat loss, though more human data is needed.


Can You Lose Weight Without Losing Muscle?


Some researchers remain skeptical, cautioning that significant fat loss often comes with some muscle loss—especially in older adults, where muscle preservation is vital for preventing falls and osteoporosis.

Still, the next generation of GLP-1 and dual GIP/GLP-1 receptor agonists, like Tirzepatide

(Mounjaro), continues to push boundaries in safe and effective obesity treatment.

Sources : The New York Times  , The New England Journal of Medicine

Comments

Post a Comment

Popular posts from this blog

Shocking Findings: Rising Plastic Pollution in the Human Brain

Image
According to a report published by Al Jazeera, a new study has revealed alarming levels of plastic accumulation in human tissues, particularly in the brain. This research, published in Nature Medicine , highlights the increasing presence of microplastics and nanoplastics in vital organs, raising serious health concerns. Led by Matthew Campen from the University of New Mexico, the study compared tissue samples from deceased individuals in 2024 with those from 2016. The findings indicate a significant surge in plastic particle concentration, with particularly high levels detected in the brain. 30 Times Higher Plastic Contamination in the Brain According to the study, plastic pollution levels in the brain were found to be 30 times higher than in other organs such as the liver and kidneys. Previous research had already detected microplastics in the lungs, intestines, and even the placenta. However, traditional microscopic techniques typically identify only particles larger than fiv...
Read more

Report: 7 Foods High-Risk Individuals Should Avoid to Prevent Diabetes

Image
A recent report from the British newspaper The Telegraph highlights a study that analyzed the health records of 4.1 million individuals over a year, aiming to identify dietary habits that can help prevent diabetes. The study reveals that adopting a healthy, plant-based diet can reduce the risk of developing diabetes by 34%. It emphasizes that lifestyle changes and improved diet quality play a critical role in preventing type 2 diabetes, a condition characterized by insulin resistance and high blood sugar levels. The Telegraph report also cautions against specific foods, especially for individuals predisposed to diabetes. Here are the seven types of food to be mindful of: 1. High-Sugar Foods and Dried Fruits     While fruits are generally a part of a healthy diet, certain types should be consumed in moderation due to their high sugar content. For instance, fruits like pineapples, bananas, red grapes, and red apples can lead to blood sugar spikes when eaten in excess....
Read more

7 Amazing Benefits of Consuming Honey with Nuts During Pregnancy

Image
Pregnancy is a transformative journey that requires extra care to ensure the health of both the mother and baby. Nutritional choices play a vital role, and many expectant mothers wonder whether certain combinations, such as honey and nuts, are safe to consume. This article explores the scientific benefits of this power-packed duo during pregnancy, emphasizing its positive impact on maternal and fetal well-being. Is It Safe to Consume Honey with Nuts During Pregnancy? Yes, honey with nuts is a safe and highly beneficial choice for pregnant women. It provides numerous advantages, including: 1. Alleviating Fatigue Pregnancy often brings bouts of fatigue, but the natural sugars and carbohydrates in honey and nuts can offer a much-needed energy boost. These nutrients help combat exhaustion and keep mothers feeling energetic throughout the day. 2. Strengthening the Immune System Honey is renowned for its antimicrobial properties, while nuts are rich in immunity-boosting nutrients...
Read more